RA CAPITAL MANAGEMENT, L.P. Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$871.4B
Holdings
22
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 5,580,690 | $154.9B | 17.78% | |
| 2 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $131.8B | 15.13% | |
| 3 | —AVEXIS INC | 1,310,046 | $107.6B | 12.35% | |
| 4 | —ACHILLION PHARMACEUTICALS INC | 13,633,220 | $62.6B | 7.18% | |
| 5 | —BIOHAVEN PHARMACTL HLDG CO LTD | 2,448,350 | $61.2B | 7.02% | |
| 6 | GTHXEURG1 THERAPEUTICS INC | 2,684,244 | $46.8B | 5.37% | |
| 7 | —IGNYTA INC | 4,016,990 | $41.6B | 4.77% | |
| 8 | ESPRESPERION THERAPEUTICS INC | 731,531 | $33.9B | 3.88% | |
| 9 | —MYOVANT SCIENCES LTD | 2,807,550 | $32.8B | 3.77% | |
| 10 | BCRXBIOCRYST PHARMACEUTICALS | 5,162,242 | $28.7B | 3.29% | |
| 11 | —RA PHARMACEUTICALS INC | 1,351,808 | $25.3B | 2.91% | |
| 12 | —RADIUS HEALTH INC | 497,157 | $22.5B | 2.58% | |
| 13 | —ZOGENIX INC | 1,474,688 | $21.4B | 2.45% | |
| 14 | —AQUINOX PHARMACEUTICALS INC | 1,396,071 | $19.6B | 2.25% | |
| 15 | —AVEO PHARMACEUTICALS INC | 8,435,584 | $18.7B | 2.15% | |
| 16 | —ACORDA THERAPEUTICS INC | 900,259 | $17.7B | 2.04% | |
| 17 | AKBAAKEBIA THERAPEUTICS INC | 836,337 | $12.0B | 1.38% | |
| 18 | GBYSANGAMO THERAPEUTICS INC | 1,250,000 | $11.0B | 1.26% | |
| 19 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $7.7B | 0.88% | |
| 20 | TGTXTG THERAPEUTICS INC | 700,000 | $7.0B | 0.81% | |
| 21 | KALVKALVISTA PHARMACEUTICALS INC | 591,070 | $4.3B | 0.50% | |
| 22 | —PROTEON THERAPEUTICS INC | 1,337,462 | $2.0B | 0.23% |